Abstract:Objective To analysis the relationship between anemia and clinic outcomes retrospectively in maintenance hemodialysis patients for Renji Hospital, Shanghai Jiao Tong University School of Medicine, China.Methods This study enrolled all maintenance hemodialysis (MHD) patients between 1 January, 2007 and 31 December, 2014 at the Renji Hospital.They were followed up until death, cessation of hemodialysis, transfer to other centers or to the end of the study (31 December, 2014).Laboratory parameters, including hemoglobin concentrations, transferrin saturation, ferritin, serum albumin, were measured every 3 months.According to the Kidney Disease Outcomes Quality Initiative (K/DOQ1) guidelines, the patients were divided into target-hemoglobin group (110≤Hb ≤ 120 g/L) and non target-hemoglobin group (＜ 110 g/L or ＞ 120 g/L), and then the compliance rate of Hb, Ferritin, transferrin saturation, and the influence factors of compliance rate of Hb as well as its relationship with the prognosis were analyzed.Results Total 517 maintenance hemodialysis patients were involved in this study.The mean age was (63.76± 14.78) years and 59.96％ patients were male.Only 35.20％, 91.26％ and 31.18％ of them met the K/DOQI defined targets for hemoglobin, transferrin saturation and ferritin levels.The average levels of TSAT and Ferritin had no significant difference between the target-hemoglobin group and the non target-hemoglobin group.Compared with patients in non target-hemoglobin group, the targets-hemoglobin group had-significantly higher-qualified rateof transferrin saturation (94.97％ vs 89.41％, P=0.045) and Ferritin (37.22％ vs 28.13％, P=0.036).Multivariate logistic regression analysis showed that the serum albumin, blood intact parathyroid hormone (iPTH) and dialysis vintage were independent risk factors that affected whether hemoglobin was up to the target.Kaplan-Meier analysis showed that the 8-year survival rate and cardiovascular survival rate in target-hemoglobin group were obviously higher than that in the non target-hemoglobin group (86.70％ vs 75.30％, x2Log rank=7.134, P=0.008;93.80％ vs 85.30％, x2Log rank=6.134, P=0.013, respectively).Dialysis frequency, age and ferritin were independent risk factors of all-cause mortality for non target-hemoglobin group, and Dialysis frequency was independent risk factors of cardio-cerebral vascular disease mortality for non target-hemoglobin group.Conclusions The compliance rate of hemoglobin in MHD patients is still not steady controlled.Blood iPTH, serum albumin and dialysis vintage are independent risk factors that affect whether hemoglobin is up to the target in MHD patients.Sub-standard hemoglobin increases both all-cause mortality and cardio-cerebral vascular disease mortality in MHD patients.

Efficacy of Intravenous Iron Supplementation in Improving Anemia in Patients Undergoing Maintenance Hemodialysis

Intravenous iron sucrose in maintenance hemodialysis patients: a prospective randomized controlled multi-center clinical trial

Comparison of Therapeutic Efficiency Between Saccharum Iron and Ferrum Dextran Iron: a Multicenter Clinical Trial

Effectiveness of intravenous iron treatment in anemic hemodialysis patients

The comparison between the efficacy of intravenous and oral iron for hemodialysis patients

Effect of frequency of intravenous iron administration on hemoglobin variability in maintenance hemodialysis patients

The Efficacy and Safety of Intravenous Iron Sucrose in the Treatment of Anemia in Maintenance Hemodialysis Patients

[Efficacy of Intravenous Drug Information Management System on the Improvement of Anemia in Maintenance Hemodialysis Patients].

Cost-effectiveness analysis of oral vs intravenous iron treatment for renal anemia patients

Clinical effect of intravenous iron dextran on peritoneal dialysis patients with renal anemia

Intravenous iron dextran treatment in chronic hemodialysis

Comparison of the Application and Effect Between Intravenous Iron Supple-mentation and Oral Iron Supplementation on Renal Anemia

The effect of iron sucrose in the treatment of renal anemia on elderly pa-tients undergoing maintenance hemodialysis:a multicenter clinical trial

Anemia, inflammation and oxidative stress in dialysis patients two years before and after alteration from oral iron to intravenous iron

Intravenous iron sucrose therapy in anemic hemodialysis patients: a prospective randonmized controlled multicentric clinical trial

Changes of Hepcidin During Anemia Treatment in Patients on Maintenance Hemodialysis

Low-Dose Ferrous Bisglycinate Chelate Supplementation in Chronic Kidney Disease and Hemodialysis Patients

Relationship between anemia and clinic outcomes in maintenance hemodialysis patients

Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study

Cross-over Study of Influence of Oral Vitamin C Supplementation on Inflammatory Status in Maintenance Hemodialysis Patients.

Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials